Inhibition of tumor growth by elimination of granulocytes
- PMID: 7807024
- PMCID: PMC2191807
- DOI: 10.1084/jem.181.1.435
Inhibition of tumor growth by elimination of granulocytes
Abstract
As observed for many types of cancers, heritable variants of ultraviolet light-induced tumors often grow more aggressively than the parental tumors. The aggressive growth of some variants is due to the loss of a T cell-recognized tumor-specific antigen; however, other variants retain such antigens. We have analyzed an antigen retention variant and found that the variant tumor cells grow at the same rate as the parental tumor cells in vitro, but grew more rapidly than the parental cells in the T cell-deficient host. The growth of the variant cells was stimulated in vitro by factors released from tumor-induced leukocytes and by several defined growth factors. In addition, the variant cancer cells actually attracted more leukocytes in vitro than the parental cells. Furthermore, elimination of granulocytes in vivo in nude mice by a specific antigranulocyte antibody inhibited the growth of the variant cancer, indicating that this tumor requires granulocytes for rapid growth.
Similar articles
-
Antigenic cancer cells that escape immune destruction are stimulated by host cells.Cancer Res. 1995 Nov 1;55(21):5094-100. Cancer Res. 1995. PMID: 7585557
-
Bystander elimination of antigen loss variants in established tumors.Nat Med. 2004 Mar;10(3):294-8. doi: 10.1038/nm999. Epub 2004 Feb 22. Nat Med. 2004. PMID: 14981514
-
Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.Cancer Res. 1989 Mar 1;49(5):1207-13. Cancer Res. 1989. PMID: 2465081
-
Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.Proc Natl Acad Sci U S A. 1984 Apr;81(7):2186-90. doi: 10.1073/pnas.81.7.2186. Proc Natl Acad Sci U S A. 1984. PMID: 6609361 Free PMC article.
-
MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.Semin Cancer Biol. 1991 Oct;2(5):321-8. Semin Cancer Biol. 1991. PMID: 1837738 Review.
Cited by
-
Arginase: an emerging key player in the mammalian immune system.Br J Pharmacol. 2009 Oct;158(3):638-51. doi: 10.1111/j.1476-5381.2009.00291.x. Epub 2009 Sep 17. Br J Pharmacol. 2009. PMID: 19764983 Free PMC article. Review.
-
A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer.Neoplasia. 2005 Dec;7(12):1112-22. doi: 10.1593/neo.05442. Neoplasia. 2005. PMID: 16354594 Free PMC article.
-
High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.Front Immunol. 2019 Jun 4;10:1141. doi: 10.3389/fimmu.2019.01141. eCollection 2019. Front Immunol. 2019. PMID: 31214164 Free PMC article.
-
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6254-8. doi: 10.1073/pnas.92.14.6254. Proc Natl Acad Sci U S A. 1995. PMID: 7603979 Free PMC article.
-
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.Nat Nanotechnol. 2016 Mar;11(3):295-303. doi: 10.1038/nnano.2015.292. Epub 2015 Dec 21. Nat Nanotechnol. 2016. PMID: 26689376 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials